Tobacco Education and Lung Health Study (TEAL) - Trial NCT06290869
Access comprehensive clinical trial information for NCT06290869 through Pure Global AI's free database. This Phase 3 trial is sponsored by Georgetown University and is currently Recruiting. The study focuses on Smoking Cessation. Target enrollment is 1188 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Phone-based Tobacco Treatment, Nicotine Replacement, and Stepped Care Intervention
Interventional
behavioral
Sponsor & Location
Georgetown University
Timeline & Enrollment
Phase 3
Feb 22, 2024
Apr 01, 2026
Primary Outcome
Biochemically verified smoking abstinence- MHS vs. QL-E arms,Biochemically verified smoking abstinence--continued MHS arm vs Stepped Care
Summary
Primary Objective To compare two smoking cessation interventions among individuals undergoing
 lung cancer screening. Primary outcomes are: 3-month self-reported abstinence from cigarettes
 and 6-month self-reported and bioverified abstinence from cigarettes.
 
 Secondary Objectives 1) To evaluate reach and engagement overall and by subgroup (e.g., race
 and ethnicity, underinsured, readiness to quit). 2) To conduct an economic analysis to
 evaluate intervention costs from the health system perspective.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06290869
Non-Device Trial